Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - local and regional nerve block

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - local and regional nerve block

ABD - İngilizce - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. only the 0.25% and 0.5% concentrations are indicated for obstetrical anesthesia (see warnings). experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0.75% concentration of bupivacaine hydrochloride in these patients. bupivacaine hydrochloride is not recommended for intravenous regional anesthesia (bier block) (see warnings). the routes of administration and indicated bupivacaine hydrochloride concentrations are: (see dosage and administration for additional information.) standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride. bupivacaine hydrochloride is contraindicated in obstetrical paracervical block anesthesia. its use in this technique has resulted in fetal bradycardia and death. bupivacaine hydrochloride is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride solutions.

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - bupivacaine hydrochloride, monohydrate - solution for injection - 2.5 milligram(s)/millilitre - amides; levobupivacaine

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - bupivacaine hydrochloride, monohydrate - solution for injection - 5 milligram(s)/millilitre - amides; levobupivacaine

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - bupivacaine hydrochloride monohydrate 5.28 mg/ml equivalent to bupivacaine hydrochloride 5mg/ml - solution for injection - 0.5% w/v - active: bupivacaine hydrochloride monohydrate 5.28 mg/ml equivalent to bupivacaine hydrochloride 5mg/ml excipient: glucose monohydrate sodium hydroxide water for injection - bupivacaine spinal heavy bnm is indicated for · intrathecal (subarachnoid, spinal) anaesthesia for surgical and obstetrical procedures · lower abdominal surgery (including caesarean section), urological and lower limb, including hip surgery, lasting 1.5 to 3 hours.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.4 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 0.5%{relative} - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 0.5%{relative}

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 0.25% - solution for injection - 0.25 % - active: bupivacaine hydrochloride monohydrate 0.25%

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - bupivacaine hydrochloride monohydrate 0.5% - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 0.5%